Clinical Trials Directory

Trials / Unknown

UnknownNCT04161599

Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial.

Oral + Parenteral Antibiotic Prophylaxis Before Colonic Surgery With vs Without Mechanical Bowel Preparation: a Prospective, Multicentric, Randomised, Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
968 (estimated)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The ORALEV Study found that preoperative oral antibiotics can reduce the incidence of surgical site infections after colonic resection, compared with no preparation. The role of mechanical bowel preparation in patients needing colonic surgery is yet to be elucidated. No randomised controlled trials have assessed the impact of mechanical bowel preparation combined with oral antibiotics on the incidence of surgical site infections after colonic surgery, compared with oral antibiotics only.

Detailed description

International, multicentre, pragmatic, parallel-group, randomised controlled trial. Routine antibiotics for the intravenous and oral prophylaxis of colorectal surgery will be used. Experimental group: Patients undergoing elective colonic surgery that involves colonic resection. The antibiotic prophylaxis in this group will be composed of: An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) and metronidazole (250mg / 8h, 3 doses) the day before surgery, plus mechanical bowel preparation with Sodium picosulfate, light magnesium oxide, and anhydrous citric acid (10 mg - 3.5 g - 10.97 g per dose/ 2 doses the day before surgery) + An intravenous antibiotics pattern of cefuroxime 1,5 g and metronidazole 1 g at anesthetic induction. Control group: Patients undergoing elective colonic surgery that involves colonic resection. The antibiotic prophylaxis in this group will be composed of: An oral antibiotic pattern of ciprofloxacin (750mg / 12h, 2 doses) and metronidazole (250mg / 8h, 3 doses) \+ An intravenous antibiotic pattern of cefuroxime 1,5 g and metronidazole 1 gr at anesthetic induction. In both groups a second intravenous dose of cefuroxime (750mg) will be administered if the intraoperative time prolongs for more than three hours or if there is an intraoperative bleeding over 1000cc. There will not be a placebo treatment. Subject compliance will be evaluated according to the usual practice in surgical care field

Conditions

Interventions

TypeNameDescription
DRUGCefuroxime (750mg) I.VExtra dosage
PROCEDUREColonic SurgeryColonic Surgery
DRUGCefuroxime 750mg oralOral prophylaxis
DRUGMetronidazole 250 MG Oral Tablet [Flagyl]Oral prophylaxis
DRUGMetronidazole 1 g IntravenousIV prophylaxis
DRUGCefuroxime 1,5 g IntravenousIV prophylaxis
DRUGSodium picosulfate, light magnesium oxide, anhydrous citric acid 10 mg/3.5 g/10.97 g OralLaxative for bowel cleansing

Timeline

Start date
2022-03-01
Primary completion
2024-06-01
Completion
2024-07-01
First posted
2019-11-13
Last updated
2022-04-26

Locations

10 sites across 6 countries: China, Greece, Italy, Russia, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT04161599. Inclusion in this directory is not an endorsement.